Kalliope
Senior Member (Voting Rights)
Chronic Fatigue Syndrome: Progress Towards Diagnosis And Treatment, Finally?
Article is written by Henry I. Miller, physician and Senior Fellow at the Pacific Research Institute. He has also been a Research Fellow at the National Institutes of Health and the founding director of the Office of Biotechnology at the FDA.
The article mentions the IOM-report, the nano needle, the hypothesis of an up-regulation of a specific receptor (CRF2), cardio-pulmonary exercise tests and the NIH conference in April.
It’s early days, but we seem to be closing in on understanding, diagnosing, and maybe even treating one of our species’ truly awful afflictions. The glacial pace of progress serves as a reminder that we need to pursue a variety of research approaches and to get expeditious regulatory reviews of treatments once they reach clinical trials.
Article is written by Henry I. Miller, physician and Senior Fellow at the Pacific Research Institute. He has also been a Research Fellow at the National Institutes of Health and the founding director of the Office of Biotechnology at the FDA.
The article mentions the IOM-report, the nano needle, the hypothesis of an up-regulation of a specific receptor (CRF2), cardio-pulmonary exercise tests and the NIH conference in April.
It’s early days, but we seem to be closing in on understanding, diagnosing, and maybe even treating one of our species’ truly awful afflictions. The glacial pace of progress serves as a reminder that we need to pursue a variety of research approaches and to get expeditious regulatory reviews of treatments once they reach clinical trials.